Further study on 1,3‐dialkylaminouracil with dimethyl acetylenedicarboxylate
Tsuneo Itoh, Ikuko Fujii, Y. TOMII, Haruo Ogura, Yoshihisa Mizuno, Norio Kawahara
Abstract
Tsuneo Itoh, Ikuko Fujii, Y. TOMII, Haruo Ogura, Yoshihisa Mizuno, Norio Kawahara
Abstract
Abstract On the treatment of 1,3‐dialkyl‐6‐alkylaminouracil (1) with dimethyl acetylenedicarboxylate (DMAD), we were able to develop a new synthesis of deazapurine (pyrrolo[2,3‐d]pyrimidine, 4), and proposed the plausible mechanism for the formation of 3 and 4 from the adduct [dimethyl 2‐(1,3‐dialkyl‐6‐alkylamino‐2,4‐dioxopyrimidin‐5‐yl)fumarate, 2] of 1 with DMAD.
OpenAlex reports 11 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract On the treatment of 1,3‐dialkyl‐6‐alkylaminouracil (1) with dimethyl acetylenedicarboxylate (DMAD), we were able to develop a new synthesis of deazapurine (pyrrolo[2,3‐d]pyrimidine, 4), and proposed the plausible mechanism for the formation of 3 and 4 from the adduct [dimethyl 2‐(1,3‐dialkyl‐6‐alkylamino‐2,4‐dioxopyrimidin‐5‐yl)fumarate, 2] of 1 with DMAD.
Key concepts: Dimethyl acetylenedicarboxylate, Chemistry, Adduct, Pyrimidine, Medicinal chemistry, Dimethyl fumarate, Stereochemistry, Organic chemistry